Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» nephropathic cystinosis
nephropathic cystinosis
Horizon's NDA for Procysbi New Dosage Form Accepted by FDA
Yahoo/Zacks.com
Sun, 07/21/19 - 04:21 pm
Horizon Therapeutics
procysbi
nephropathic cystinosis
Raptor's Procysbi approved for rare disease in EU
PharmaTimes
Sat, 09/14/13 - 11:05 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Will You Adopt This Orphan Drug?
Motley Fool
Sat, 09/7/13 - 12:00 pm
nephropathic cystinosis
Raptor Pharmaceuticals
procysbi
US Exclusivity for Raptor's Procysbi
Yahoo/Zacks
Wed, 06/26/13 - 10:37 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
orphan drugs
Raptor Pharma's Procysbi Launched in the US
Yahoo/Zacks
Sat, 06/22/13 - 10:14 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
Pharmabiz
Sun, 05/5/13 - 11:07 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Raptor's FDA Approval Is New Test For Orphan Drug Pricing
TheStreet.com
Wed, 05/1/13 - 09:09 am
FDA
Raptor Pharmaceuticals
orphan drugs
procysbi
nephropathic cystinosis
Why Raptor Could Run Up To Its PDUFA
Seeking Alpha
Tue, 02/12/13 - 10:59 am
Raptor Pharmaceuticals
Mylan
nephropathic cystinosis
RP103
Raptor To Rise On Proven Strategy & Upcoming FDA Decision
Seeking Alpha
Sat, 12/29/12 - 10:31 am
Raptor
procysbi
nephropathic cystinosis
Raptor Drug FDA Action Date Delayed
Yahoo/Zacks
Fri, 12/28/12 - 11:26 am
FDA
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Raptor Pharma Says FDA Extends PROCYSBI NDA Review By 3 Months
NASDAQ
Sat, 12/22/12 - 01:00 pm
procysbi
Raptor Pharmaceuticals
nephropathic cystinosis
Raptor Pharmaceuticals announces positive data on RP103 extension study
The Fly on the Wall
Mon, 11/5/12 - 11:02 am
RP103
Raptor Pharmaceuticals
nephropathic cystinosis
Raptor Pharma Rises as FDA Starts Drug Review
PharmPro
Sat, 06/16/12 - 01:52 pm
RP103
Raptor Pharmaceuticals
nephropathic cystinosis
Raptor Pharmaceutical Corp. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis
Pipeline Review
Sat, 03/31/12 - 01:11 pm
Raptor Pharmaceuticals
RP103
nephropathic cystinosis
Raptor Pharmaceuticals: Pipeline Worth a Closer Look
Seeking Alpha
Thu, 03/31/11 - 09:26 am
Raptor Pharmaceuticals
DR Cysteamine
nephropathic cystinosis